Type 2 Diabetes
By FormBlends Medical Team · Last reviewed April 2026
Type 2 diabetes is a chronic metabolic condition in which the body becomes resistant to insulin and the pancreas gradually loses the ability to produce enough insulin to maintain normal blood sugar. It affects over 37 million Americans and is the seventh leading cause of death in the United States. GLP-1 receptor agonists have become a cornerstone of modern diabetes management.
Affects over 37 million Americans
FormBlends Condition Context
Reviewed May 14, 2026Treat Type 2 Diabetes condition guide as context for a safer next conversation. It should help with connect symptoms and treatment options to a safer provider conversation, while keeping the reader focused on condition-specific care, evidence limits, provider oversight, and the difference between general information and personal medical advice.
- Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
- Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
- Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.
Common Symptoms
- Elevated fasting blood glucose above 126 mg/dL
- HbA1c at or above 6.5%
- Increased thirst and frequent urination
- Unexplained weight loss despite increased appetite
- Blurred vision from glucose-induced lens changes
- Slow wound healing and frequent infections
- Tingling or numbness in hands and feet
Common Causes
- Progressive insulin resistance from obesity and visceral fat
- Beta-cell dysfunction and declining insulin secretion
- Genetic predisposition with family history
- Sedentary lifestyle and poor dietary patterns
- Chronic inflammation driving metabolic dysfunction
Treatment Options
GLP-1 Agonists (Semaglutide/Tirzepatide)
GLP-1 agonists improve glycemic control through glucose-dependent insulin secretion, reduced glucagon output, and weight loss that addresses the root driver of insulin resistance.
Learn more about GLP-1 Agonists (Semaglutide/Tirzepatide) →Metformin
Metformin remains a first-line medication for type 2 diabetes, reducing hepatic glucose output and improving insulin sensitivity in peripheral tissues.
Dietary and Exercise Intervention
Structured diet modification reducing glycemic load combined with both aerobic and resistance exercise can produce meaningful improvements in HbA1c and may achieve remission in early-stage disease.
Find Treatment for Type 2 Diabetes
Browse clinics near you that treat type 2 diabetes.
Find Clinics